Safety of concomitant administration of seasonal and/or H1N1 Flu vaccination in patients receiving erlotinib for advanced non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 5, Issue 5, 2010, Pages 752-754

  Spitaleri, Gianluca ^a   Delmonte, Angelo ^a   Toffalorio, Francesca ^a   De Pas, Tommaso Martino ^a   Gregorc, Vanesa ^b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b IRCS S Raffaele   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ERLOTINIB; INFLUENZA VACCINE;

ADVANCED CANCER; ADVERSE DRUG REACTION; ALOPECIA; DRUG SAFETY; HUMAN; INFLUENZA VACCINATION; INTERVIEW; LETTER; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; RASH;

EID: 77951815657     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181d6b8a1     Document Type: Letter

References (3)

1. Yousuf HM, Englund J, Couch R, et al. Influenza among hospitalized adults with leukemia. Clin Infect Dis 1997;24:1095-1099.
2. Kelly H, Barr I. Large trials confirm immunogenicity of H1N1 vaccines. Lancet 2010;375: 6-9.
3. Anderson H, Petrie K, Berrisford C, et al. Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer 1999;80:219-220.